A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
THIS IS THE SECOND PART OF A 2-PART STUDY. The purpose of the first part of this study was to determine the safety and tolerability of ascending doses of valproic acid (also known as Depacon) administered as intravenous infusion (IV) in doses ranging from 15 mg/kg to 250 mg/kg in healthy subjects. ID: VPA-C-002 The second part of the study will also be to determine the safety and tolerability of single ascending doses of valproic acid administered as IV in trauma subjects with hemorrhagic shock.
Epistemonikos ID: 2e1d45bd649847e174991a0fb6c758048d92aeda
First added on: May 17, 2024